Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $6.32M | $0.77 | $32.67 | 4,142.47% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $17.08M | $0.33 | $10.00 | 2,912.05% | Strong Buy | 2 | N/A | N/A | -27,082.36% | -387.16% | |||
| CANF | CAN-FITE BIOPHARMA LTD | $3.69M | $0.31 | $6.75 | 2,077.42% | Strong Buy | 2 | 209.62% | N/A | 0.00% | 0.00% | |||
| MBRX | MOLECULIN BIOTECH INC | $9.84M | $4.83 | $100.00 | 1,970.39% | Buy | 2 | N/A | N/A | N/A | -43.07% | |||
| GRI | GRI BIO INC | $3.96M | $1.21 | $23.00 | 1,800.83% | Buy | 2 | N/A | -80.86% | -59.63% | -24.85% | |||
| NRXP | NRX PHARMACEUTICALS INC | $62.10M | $2.21 | $36.50 | 1,551.58% | Strong Buy | 4 | 1,164.95% | N/A | -556.39% | 955.57% | |||
| ACET | ADICET BIO INC | $84.14M | $0.55 | $8.50 | 1,448.27% | Strong Buy | 2 | N/A | N/A | -39.39% | -30.60% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $162.53M | $0.48 | $7.00 | 1,349.28% | Buy | 3 | 52.10% | N/A | 842.99% | 59.37% | |||
| SKYE | SKYE BIOSCIENCE INC | $36.55M | $1.14 | $15.00 | 1,215.79% | Buy | 3 | N/A | N/A | -133.44% | -106.03% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $47.89M | $2.19 | $26.67 | 1,117.67% | Buy | 3 | 227.16% | N/A | N/A | -54.28% | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $12.59M | $1.17 | $14.00 | 1,096.58% | Buy | 2 | N/A | N/A | -51.33% | -43.90% | |||
| TVRD | TVARDI THERAPEUTICS INC | $42.50M | $4.53 | $53.60 | 1,083.22% | Strong Buy | 5 | N/A | N/A | -102.26% | -73.03% | |||
| VNRX | VOLITIONRX LTD | $34.38M | $0.28 | $3.25 | 1,060.71% | Strong Buy | 2 | 211.69% | N/A | -283.89% | 1,524.72% | |||
| LSTA | LISATA THERAPEUTICS INC | $18.17M | $2.06 | $23.50 | 1,040.78% | Strong Buy | 2 | 101.85% | N/A | -50.75% | -40.52% | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $392.85M | $3.63 | $39.50 | 988.15% | Buy | 8 | N/A | N/A | -36.95% | -31.49% | |||
| PSTV | PLUS THERAPEUTICS INC | $92.08M | $0.67 | $7.25 | 982.09% | Strong Buy | 4 | 55.97% | N/A | -138.68% | -37.54% | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $23.32M | $0.96 | $10.00 | 941.67% | Strong Buy | 2 | N/A | N/A | -133.24% | -111.24% | |||
| NAKA | KINDLY MD INC | $196.17M | $0.45 | $4.50 | 908.97% | Strong Buy | 2 | 386.36% | N/A | -1.88% | -1.30% | |||
| SLN | SILENCE THERAPEUTICS PLC | $295.39M | $6.26 | $61.67 | 885.10% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| IFRX | INFLARX NV | $71.13M | $1.05 | $10.00 | 852.38% | Buy | 3 | 202.47% | N/A | -69.43% | -48.34% | |||
| KRRO | KORRO BIO INC | $73.74M | $7.83 | $74.17 | 847.22% | Buy | 6 | -51.35% | N/A | -72.89% | -44.68% | |||
| CING | CINGULATE INC | $26.69M | $3.95 | $37.00 | 836.71% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| OSTX | OS THERAPIES INC | $70.08M | $1.99 | $18.50 | 829.65% | Strong Buy | 2 | N/A | N/A | -98.75% | -40.12% | |||
| IMUX | IMMUNIC INC | $82.15M | $0.68 | $6.33 | 827.23% | Strong Buy | 3 | N/A | N/A | -147.22% | -37.97% | |||
| PDSB | PDS BIOTECHNOLOGY CORP | $49.96M | $1.02 | $9.00 | 782.35% | Strong Buy | 2 | N/A | N/A | -330.30% | -89.97% | |||
| AKTX | AKARI THERAPEUTICS PLC | $27.16M | $0.38 | $3.30 | 768.42% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| ONCY | ONCOLYTICS BIOTECH INC | $102.60M | $0.99 | $8.50 | 758.59% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| FEMY | FEMASYS INC | $50.47M | $0.86 | $7.25 | 740.09% | Strong Buy | 2 | 112.07% | N/A | -327.29% | -91.54% | |||
| CYBN | CYBIN INC | $137.51M | $5.97 | $49.33 | 726.35% | Strong Buy | 3 | N/A | N/A | -78.27% | -60.02% | |||
| CTSO | CYTOSORBENTS CORP | $41.26M | $0.66 | $5.38 | 718.11% | Buy | 2 | 26.52% | N/A | N/A | N/A | |||
| ZSPC | ZSPACE INC | $14.53M | $0.50 | $4.00 | 700.00% | Strong Buy | 2 | -5.46% | N/A | N/A | -178.34% | |||
| PMN | PROMIS NEUROSCIENCES INC | $19.59M | $9.10 | $71.50 | 685.71% | Strong Buy | 2 | N/A | N/A | -337.19% | -144.37% | |||
| ATYR | ATYR PHARMA INC | $79.96M | $0.82 | $6.33 | 676.10% | Buy | 3 | 549.70% | N/A | -17.23% | -12.96% | |||
| AMTX | AEMETIS INC | $98.35M | $1.50 | $11.50 | 666.67% | Strong Buy | 2 | 62.48% | N/A | -21.94% | 27.74% | |||
| MYO | MYOMO INC | $41.13M | $1.07 | $7.67 | 616.54% | Buy | 3 | 11.05% | N/A | 18.58% | 7.97% | |||
| IBRX | IMMUNITYBIO INC | $2.27B | $2.30 | $16.00 | 595.65% | Strong Buy | 2 | 84.00% | N/A | -70.90% | 71.63% | |||
| SNTI | SENTI BIOSCIENCES INC | $39.17M | $1.49 | $10.33 | 593.49% | Strong Buy | 3 | N/A | N/A | -617.50% | -95.18% | |||
| HUMA | HUMACYTE INC | $237.83M | $1.27 | $8.67 | 582.44% | Strong Buy | 6 | 277.66% | N/A | -8,282.35% | 430.01% | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $189.56M | $1.56 | $10.50 | 573.08% | Strong Buy | 2 | 111.86% | N/A | N/A | -574.54% | |||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $20.73M | $1.81 | $11.50 | 535.36% | Strong Buy | 2 | 130.00% | N/A | -2.51% | -1.66% | |||
| ZYXI | ZYNEX INC | $26.44M | $0.87 | $5.50 | 532.18% | Buy | 2 | 3.82% | N/A | N/A | -19.15% | |||
| TCRX | TSCAN THERAPEUTICS INC | $58.45M | $1.03 | $6.50 | 531.07% | Buy | 2 | 22.33% | N/A | -36.77% | -20.20% | |||
| CODX | CO-DIAGNOSTICS INC | $21.80M | $0.36 | $2.25 | 528.49% | Strong Buy | 2 | 201.95% | N/A | 73.29% | 65.25% | |||
| JSPR | JASPER THERAPEUTICS INC | $52.33M | $1.87 | $11.43 | 511.18% | Buy | 7 | N/A | N/A | -416.07% | -83.77% | |||
| ARTV | ARTIVA BIOTHERAPEUTICS INC | $75.35M | $3.07 | $18.67 | 508.05% | Buy | 3 | N/A | N/A | -60.06% | -52.14% | |||
| CABA | CABALETTA BIO INC | $232.96M | $2.42 | $14.60 | 503.31% | Strong Buy | 5 | N/A | N/A | -93.64% | -68.82% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.